n-acetylmannosamine has been researched along with Distal Muscular Dystrophies in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 6 (85.71) | 24.3611 |
| 2020's | 1 (14.29) | 2.80 |
| Authors | Studies |
|---|---|
| Bayman, L; Berry, SM; Bradley, K; Carrillo, N; Ciccone, C; Class, B; Coffey, CS; Driscoll, C; Gahl, WA; Heiss, JD; Huizing, M; Jodarski, C; Joe, G; Leoyklang, P; Liu, CY; Malicdan, MC; Parks, R; Perreault, J; Quintana, M; Shrader, JA; Slota, C; Van Wart, S | 1 |
| Carrillo, N; Celeste, F; Ciccone, C; Cradock, J; Gahl, WA; Goldspiel, B; Huizing, M; Latham, LL; Malicdan, MC; McKew, JC; Terse, P; Wang, AQ; Xu, X; Yang, N; Yorke, S | 1 |
| Cho, A; Hayashi, YK; Malicdan, MC; Mine, T; Nishino, I; Noguchi, S; Nonaka, I; Yamamoto, T; Yonekawa, T | 1 |
| Malicdan, MC; Nishino, I; Noguchi, S | 1 |
| Goto, Y; Hayashi, YK; Malicdan, MC; Nishino, I; Noguchi, S; Nonaka, I; Tokutomi, T | 1 |
| Aoki, M | 1 |
| Anikster, Y; Ciccone, C; Gahl, WA; Huizing, M; Jacobs, K; Kurochkina, N; Niethamer, TK; Yardeni, T | 1 |
1 review(s) available for n-acetylmannosamine and Distal Muscular Dystrophies
| Article | Year |
|---|---|
[Animal model of distal myopathy with rimmed vacuoles/hereditary inclusion body myopathy and preclinical trial with sugar compounds].
Topics: Administration, Oral; Animals; Disease Models, Animal; Distal Myopathies; Drug Evaluation, Preclinical; Hexosamines; Humans; Inclusion Bodies; Lactose; Mice; Mice, Transgenic; N-Acetylneuraminic Acid; Sialic Acids; Vacuoles | 2010 |
2 trial(s) available for n-acetylmannosamine and Distal Muscular Dystrophies
| Article | Year |
|---|---|
Safety and efficacy of N-acetylmannosamine (ManNAc) in patients with GNE myopathy: an open-label phase 2 study.
Topics: Adult; Distal Myopathies; Hexosamines; Humans; Muscular Diseases; N-Acetylneuraminic Acid | 2021 |
Safety, pharmacokinetics and sialic acid production after oral administration of N-acetylmannosamine (ManNAc) to subjects with GNE myopathy.
Topics: Administration, Oral; Adult; Aged; Alleles; Animals; Distal Myopathies; Dose-Response Relationship, Drug; Double-Blind Method; Female; Hexosamines; Homozygote; Humans; Male; Middle Aged; Muscles; Mutation; N-Acetylneuraminic Acid; Phosphotransferases (Alcohol Group Acceptor) | 2017 |
4 other study(ies) available for n-acetylmannosamine and Distal Muscular Dystrophies
| Article | Year |
|---|---|
Sialyllactose ameliorates myopathic phenotypes in symptomatic GNE myopathy model mice.
Topics: Aging; Amyloid beta-Peptides; Animals; Body Weight; Cells, Cultured; Creatine Kinase; Disease Models, Animal; Distal Myopathies; Enzyme-Linked Immunosorbent Assay; Hexosamines; Lactose; Mice; Muscle Contraction; Muscle, Skeletal; Mutation; Myoblasts; N-Acetylneuraminic Acid; Peptide Fragments; Phenotype | 2014 |
Peracetylated N-acetylmannosamine, a synthetic sugar molecule, efficiently rescues muscle phenotype and biochemical defects in mouse model of sialic acid-deficient myopathy.
Topics: Animals; Disease Models, Animal; Distal Myopathies; Hexosamines; Humans; Mice; Mice, Transgenic; Muscle, Skeletal; N-Acetylneuraminic Acid | 2012 |
[109th Scientific Meeting of the Japanese Society of Internal Medicine: symposium: 2. Translational research and evidence-based medicine (EBM) in internal medicine in Japan, translational research; 3) Development of therapy for amyotrophic lateral scleros
Topics: Adult; Amyotrophic Lateral Sclerosis; Animals; Distal Myopathies; Hepatocyte Growth Factor; Hexosamines; Humans; Translational Research, Biomedical | 2012 |
Murine isoforms of UDP-GlcNAc 2-epimerase/ManNAc kinase: Secondary structures, expression profiles, and response to ManNAc therapy.
Topics: Amino Acid Sequence; Animals; Distal Myopathies; Hexosamines; Isoenzymes; Mice; Mice, Inbred C57BL; Molecular Sequence Data; Multienzyme Complexes; Mutation, Missense; Organ Specificity; Protein Structure, Secondary; Transcription, Genetic | 2013 |